SEATTLE, May 03, 2017 -- Expeditors International of Washington, Inc. (NASDAQ:EXPD), today announced that on May 2, 2017, its Board of Directors declared a semi-annual cash dividend of $0.42 per share, payable on June 15, 2017 to shareholders of record as of June 1, 2017.
Expeditors is a global logistics company headquartered in Seattle, Washington. The company employs trained professionals in 177 district offices and numerous branch locations located on six continents linked into a seamless worldwide network through an integrated information management system. Services include the consolidation or forwarding of air and ocean freight, customs brokerage, vendor consolidation, cargo insurance, time-definite transportation, order management, warehousing and distribution and customized logistics solutions.
CONTACTS: Jeffrey S. Musser President and Chief Executive Officer (206) 674-3433 Bradley S. Powell Senior Vice President and Chief Financial Officer (206) 674-3412 Geoffrey Buscher Director - Investor Relations (206) 892-4510


Google Secures Pentagon AI Deal for Classified Projects
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Toyota Global Vehicle Sales Decline in March Amid RAV4 Transition and Middle East Slowdown
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth 



